Biophysical delivery of peptides: Applicability for cancer therapy

被引:10
作者
Dass, Crispin R.
Choong, Peter F. M.
机构
[1] Univ Melbourne, St Vincent Hosp, Dept Orthopaed, Fitzroy, Vic 3065, Australia
[2] Peter MacCallum Canc Ctr, Bone & Soft Tissue Sarcoma Serv, Melbourne, Vic 3000, Australia
关键词
peptide; protein; drug delivery; cancer; device; cell therapy;
D O I
10.1016/j.peptides.2006.08.016
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
There is a current trend towards evaluation of molecular agents for treatment of a variety of ailments, including cancer. One class of such biomolecules is proteins, and their shortened versions, peptides. Use of peptidic entities has been hindered by poor bioavailability in vivo and the high cost involved in mass-producing these macromolecular drugs. The need for localized delivery is being met with the development of various biophysical means, which include devices and aids, mainly transdermal and invasive implants. In addition, various cell-based delivery modalities, which include the use of spore-forming bacteria and stem cells, are being explored. This review discusses these methods in turn, and examines ways by which these can be enhanced for peptide delivery to tumors. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:3479 / 3488
页数:10
相关论文
共 51 条
  • [1] Drug delivery systems: Entering the mainstream
    Allen, TM
    Cullis, PR
    [J]. SCIENCE, 2004, 303 (5665) : 1818 - 1822
  • [2] TRANSDERMAL DELIVERY OF PEPTIDE AND PROTEIN DRUGS - AN OVERVIEW
    AMSDEN, BG
    GOOSEN, MFA
    [J]. AICHE JOURNAL, 1995, 41 (08) : 1972 - 1997
  • [3] A continuous delivery system of IL-1 receptor antagonist reduces angiogenesis and inhibits tumor development
    Bar, D
    Apte, RN
    Voronov, E
    Dinarello, CA
    Cohen, S
    [J]. FASEB JOURNAL, 2004, 18 (01) : 161 - 163
  • [4] Bremseth D L, 2001, Diabetes Technol Ther, V3, P225
  • [5] Dermal and transdermal drug delivery systems: Current and future prospects
    Brown, MB
    Martin, GP
    Jones, SA
    Akomeah, FK
    [J]. DRUG DELIVERY, 2006, 13 (03) : 175 - 187
  • [6] Direct insulin signaling of neurons reverses diabetic neuropathy
    Brussee, V
    Cunningham, FA
    Zochodne, DW
    [J]. DIABETES, 2004, 53 (07) : 1824 - 1830
  • [7] IGG ANTIBODY-RESPONSE TO POLYETHYLENE GLYCOL-MODIFIED ADENOSINE-DEAMINASE IN PATIENTS WITH ADENOSINE-DEAMINASE DEFICIENCY
    CHAFFEE, S
    MARY, A
    STIEHM, ER
    GIRAULT, D
    FISCHER, A
    HERSHFIELD, MS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (05) : 1643 - 1651
  • [8] Stem cell-derived erythroid cells mediate long-term systemic protein delivery
    Chang, Alex H.
    T Stephan, Matthias
    Sadelain, Michel
    [J]. NATURE BIOTECHNOLOGY, 2006, 24 (08) : 1017 - 1021
  • [9] Transdermal protein delivery by a coadministered peptide identified via phage display
    Chen, YP
    Shen, YY
    Guo, X
    Zhang, CS
    Yang, WJ
    Ma, ML
    Liu, S
    Zhang, MB
    Wen, LP
    [J]. NATURE BIOTECHNOLOGY, 2006, 24 (04) : 455 - 460
  • [10] One day exposure to FGF-2 was sufficient for the regenerative repair of full-thickness defects of articular cartilage in rabbits
    Chuma, H
    Mizuta, H
    Kudo, S
    Takagi, K
    Hiraki, Y
    [J]. OSTEOARTHRITIS AND CARTILAGE, 2004, 12 (10) : 834 - 842